From curative treatments for Hepatitis C to gene therapy to immuno-oncology, a new age of transformative healthcare therapies has arrived. As more of these cutting-edge treatments are approved and marketed for rare, specialty and large populations,…
New payment models / Healthcare
Large American public companies have repurchased their shares at a remarkable rate. S&P 500 companies acquired $166.3 billion of their own shares in the first quarter of 2016, more than in any other quarter since the financial crisis. This…
Investor perspectives on public companies
Appointing the right CEO and aligning incentives with long-term strategy help position a company for long-term success. Accomplishing this in the face of short-term pressure from markets and external observers is a common challenge for boards. In…
Executive Compensation
For most of the history of modern insurance, regulation has been a local affair, shaped by the laws, conditions, and customs of specific geographies. In the United States, this meant a regulatory regime focused at the state level, with few…
Regulation and supervision / Insurance and Asset Management
“We need to revolutionize our business because the world has changed so much. It’s only through the concept of us becoming an applied technology company that we’ll achieve it. ”
—John Cryan, CEO, Deutsche Bank
Since the financial crisis,…
Financial Strategy, Innovation and technology / Banking
On May 17, 2016, members of the Lead Director Network (LDN) met in New York City to discuss board leadership challenges, especially those involving CEO and director performance. This issue of ViewPoints synthesizes the key points that emerged from…
Board and committee effectiveness
On 7–8 April 2016, members of the European Audit Committee Leadership Network (EACLN) met in London for their 25th stand-alone meeting. One session was a dialogue with audit regulators and policymakers in the European Union (EU), including the…
Corporate and board regulatory matters
On 7–8 April 2016, members of the European Audit Committee Leadership Network (EACLN) met in London for their 25th stand-alone meeting. In one session, they were joined by Gary Retelny, president and CEO of Institutional Shareholder Services (ISS),…
Corporate and board regulatory matters
“As a board member, you have to think about culture,” said one director. Conversations with dozens of leading insurers confirm not only that board members view organizational culture as an important topic but also that they are increasingly focused…
Conduct and culture, Regulation and supervision, Financial Strategy / Insurance and Asset Management
“Getting the right diagnosis is a key aspect of health care: It provides an explanation of a patient’s health problem and informs subsequent health care decisions … improving the diagnostic process is not only possible, but also represents a moral,…
Precision medicine and diagnostics / Healthcare